Portage biotech announces voluntary delisting from the canadian securities exchange

Common shares will be consolidated on the nasdaq exchange where shareholders can continue trading under the symbol "prtg"westport, connecticut--(newsfile corp. - april 16, 2021) -  portage biotech inc., (nasdaq: prtg) (cse: pbt.u) ("portage" or the "company") a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that it plans to voluntarily delist its common shares ("shares") from the canadian securities exchange (the "cse"). since portage's shares began trading on the nasdaq capital market ("nasdaq") in february 2021, the majority of active trading has shifted to nasdaq....
ATON Ratings Summary
ATON Quant Ranking